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Abstract
Background: The plasma cholesterol and triacylglycerol lowering effects of Tamarindus indica extract have been previously
described. We have also shown that the methanol extract of T. indica fruit pulp altered the expression of lipid-associated
genes including ABCG5 and APOAI in HepG2 cells. In the present study, effects of the same extract on the release of proteins
from the cells were investigated using the proteomics approach.
Methodology/Principal Findings: When culture media of HepG2 cells grown in the absence and presence of the methanol
extract of T. indica fruit pulp were subjected to 2-dimensional gel electrophoresis, the expression of seven proteins was
found to be significantly different (p,0.03125). Five of the spots were subsequently identified as alpha enolase (ENO1),
transthyretin (TTR), apolipoprotein A-I (ApoA-I; two isoforms), and rab GDP dissociation inhibitor beta (GDI-2). A functional
network of lipid metabolism, molecular transport and small molecule biochemistry that interconnects the three latter
proteins with the interactomes was identified using the Ingenuity Pathways Analysis software.
Conclusion/Significance: The methanol extract of T. indica fruit pulp altered the release of ENO1, ApoA-I, TTR and GDI-2
from HepG2 cells. Our results provide support on the effect of T. indica extract on cellular lipid metabolism, particularly that
of cholesterol.
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Introduction
Tamarindus indica, also known as tamarind, is a tropical fruit tree
that grows naturally in many tropical and subtropical regions. Due
to the sour taste, its fruit pulp is widely used to add flavour in
cooking. Many claims have been made on the medicinal use of
tamarind fruit pulps including as gentle laxative, expectorant, anti-
pyretic and antimicrobial agents [1,2,3]. Biochemical experiments
have also shown that tamarind extracts possess high antioxidant
activities [4,5]. In addition, the fruit pulp extract of T. indica has
also been shown to cause a decrease in the levels of serum total
cholesterol and triacylglycerol but an increase in the HDL
cholesterol levels in hypercholesterolaemic hamsters [4] and in
humans [5]. However, the precise mechanisms of action at the
molecular levels have yet to be deciphered.
Analysis of the methanol extract of the tamarind fruit pulp by
HPLC revealed the predominant presence of proanthocyanidins,
including (+)-catechin and (–)-epicatechin [6]. The jasmine green
tea epicatechin has been shown to reduce the levels of
triacylglycerol and cholesterol in the sera of hamsters fed with
a high-fat diet [7]. The observed hypolipidaemic effects of
epicatechin were postulated to involve inhibition of the absorption
of dietary fat and/or cholesterol or through the reabsorption of
bile acids since it did not inhibit liver HMGCoA reductase [7].
More recently, we have shown that the methanol extract of T.
indica fruit pulps significantly up-regulated the expression of a total
of 590 genes and down-regulated 656 genes expression in HepG2
cells [8]. Amongst the genes that were altered in expression were
those that encode proteins associated with lipoprotein metabolism,
including ApoA-I, ApoA-IV, ApoA-V and ABCG5 but not the
HMGCoA reductase. Both ApoA-I and ABCG5 are involved in
the reverse cholesterol transport, where the latter, together with
ABCG8, are involved in the hepatobiliary cholesterol secretion.
In the present study, we have investigated the effects of T. indica
fruit pulp extract on the release of proteins from HepG2 cells as
a mean to validate previously reported gene expression data at the
protein level. Identification of proteins that were differently altered
in the cell culture media may help to improve our understanding
of the metabolic pathways that are affected and the molecular
mechanisms involved. Secreted proteins were specifically targeted
in this study as they may be involved in regulating the many
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39476biological processes throughout the human body, including lipid
metabolism.
Materials and Methods
Preparation of methanol extract of the T. indica fruit pulp
The T. indica fruit pulp extract was prepared as previously
described [8], with slight modifications. Briefly, ripe fruit pulp of
T. indica was separated from the seeds, air-dried and then
powdered. The powdered fruit pulp (10 g) was then placed in
a conical flask and soaked in 200 ml methanol at room
temperature (RT). The mixture was then stirred with a magnetic
stirrer for 1 h and kept in the dark for 24 h The resulting extract
was then filtered and dried in a rotary evaporator and finally
redissolved in 10% DMSO. Samples were kept at 220uC until
further analysis.
Cell culture
The human hepatoma HepG2 cell line (ATCC, Manassas, VA,
USA) was grown in a complete medium consisting of Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 5 mM
glucose, 10% foetal bovine serum (FBS; HyClone, Australia),
0.37% (w/v) sodium bicarbonate and 0.48% (w/v) HEPES,
pH 7.4, in a CO2 humid incubation chamber at 37uC.
Treatment of HepG2 cells with T. indica fruit pulp
methanol extract
HepG2 cells were seeded at a density of 9.0610
6 in a 75 cm
2
flask for 18–24 h followed by extensive washing with phosphate-
buffered saline (PBS). The cells were then incubated for 24 h in
serum-free medium in the presence of 0.02% DMSO (vehicle) as
controls or a final concentration of 60 mg/ml methanol extract of
T. indica fruit pulp. Secreted proteins were harvested from the cell
culture media after 24 h incubation.
Recovery of secreted proteins from cell culture media
Cell culture media containing the secreted proteins were
centrifuged at 10006g for 5 min and filtered through a 0.22 mm
syringe filter to remove cellular debris. The supernatant was then
concentrated using a Vivaspin column with a 5 kDa molecular
weight cut off membrane (Sartorius Stedim, Germany) and
centrifuged at 70006g for 2 h. The concentration of protein was
then determined using the Bradford assay kit (Bio-rad, Hercules,
CA, USA).
Determination of cell viability
Viability of cells cultured in serum-free media in the presence of
the methanol extract of T. indica fruit pulp was estimated using 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) assay. Cells were plated at a density of 1.5610
4 cells per
well in a 6-well plate and cultured in complete DMEM for 24 h.
The cells were then washed with PBS three times and cultured in
either complete or serum-free media with or without the methanol
extract of T. indica fruit pulp. After 24 h, 100 ml of 5 mg/ml MTT
(Merck, Germany) was added to each well. Cells were further
incubated for 4 h and the MTT solution was then discarded. The
precipitate in each well was then resuspended in 2 ml of
isopropanol. The optical density (OD) of the samples was read
at 570 nm.
Two-dimensional gel electrophoresis (2D-GE)
Secreted proteins (40 mg) were first cleaned using the 2D clean-
up kit (GE Healthcare, Piscataway, USA). The resulting protein
pellet was then reconstituted in a rehydration solution, which
contains 7 M urea, 2 M thiourea, 2% w/v CHAPS, 0.5% v/v IPG
Figure 1. MTT analysis to assess cell viability. HepG2 cells were grown in complete or serum-free media (A) and in serum-free media in the
presence of vehicle, 0.02% DMSO (control) or 60 mg/ml methanol extract of the T. indica fruit pulp (B). Assays were done in triplicate and all data are
expressed as mean 6 S.E.M.
doi:10.1371/journal.pone.0039476.g001
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strips (13 cm, non-linear, pH 3–10, GE Healthcare, Uppsala,
Sweden) were rehydrated for 18 h at room temperature in the
presence of treated and untreated samples containing the same
amount of proteins. Isoelectric focusing was performed under the
following conditions: (i) 500 V, 1hr 10 mins, step and hold; (ii)
1000 V, 1 hr, gradient; (iii) 8000 V, 2 hrs 30 mins, gradient and
(iv) 8000 V, 55 mins, step and hold. The temperature was
maintained at 20uC and the current was kept at 50 mA per strip.
Upon completion, strips were equilibrated in buffer containing 6M
urea, 75 mM Tris-HCl, pH 8.8, 29.3% v/v glycerol, 2% w/v
SDS, 0.002% w/v bromophenol blue and 1% w/v DTT for
15 min, followed by a second equilibration using the same buffer
containing 4.5% w/v iodoacetamide instead of DTT for another
15 min. The second dimension separation was carried out at 15uC
on 12.5% SDS slab gels using the SE 600 Ruby electrophoresis
system (GE Healthcare, Uppsala, Sweden). The IPG strips were
sealed on the top of the gels with 0.5% (w/v) agarose in SDS-
electrophoresis buffer (25 mM Tris base, 192 mM glycine, 0.1%
w/v SDS and a trace amount of bromophenol blue). SDS-PAGE
was run at a constant power of 1 W/gel for 20 min, and then
switched to 20 W/gel until the bromophenol blue marker was
1 mm away from the bottom of the gel. The gels were silver-
stained with PlusOne Silver Staining Kit (GE Healthcare,
Uppsala, Sweden) and scanned with the ImageScanner III (GE
Healthcare, Uppsala, Sweden).
Image and data analysis
Gel images were analysed using the ImageMaster 2D Platinum
V 7.0 software (GE Healthcare, Uppsala, Sweden). Briefly, the 2D
gel images were subjected to spot detection and quantification in
the differential in-gel analyses module. To minimize variations
between gels within the same group, protein spots were
normalized using percentage of volume. Statistically significance
(p,0.05, Student’s t-test) and presence in all 4 gels were the two
criteria for acceptance of the differentially-expressed protein spots.
Selected spots were filtered based on an average expression level
change of at least 1.5-fold. The spots were then further subjected
to false discovery rate analysis using Benjamini-Hochberg’s
method to exclude false positive results [9].
Figure 2. Analysis of proteins released from HepG2 cells. Two-
dimensional gel electrophoresis (2D-GE) analysis of proteins released
from HepG2 cells in control (A) and treatment with 60 mg/ml methanol
extract of the T. indica fruit pulp (B). Analysis was performed on four
independent biological replicates for proteins released from the control
as well as treated cells. Approximately 1500 spots per gel within the
pH 3–10 range were detected. Seven spots (circled and labeled) were
differentially expressed (p,0.05) in which four were significantly up-
regulated and three were significantly down-regulated.
doi:10.1371/journal.pone.0039476.g002
Table 1. Mean percentage of spot volume of proteins that
were differentially expressed.
Spot ID
Average Percentage of Volume
6
SEM p-value
Fold
Change
Control Treated
19* 0.22360.058 0.07460.015 0.0478 23.0
46 0.73160.205 0.28960.136 0.0113 –2.5
148 0.21460.014 0.09660.014 ,0.001 –2.2
284* 0.05660.012 0.02460.005 0.0426 22.3
460 0.29260.103 0.61360.194 0.0265 +2.1
468 0.17560.023 0.34960.098 0.0136 +2.0
661 0.03460.014 0.07060.012 0.0084 +2.1
666 0.04560.021 0.11360.014 0.0018 +2.5
810 0.47560.095 0.27860.088 0.0227 –1.7
*Spots 19 and 284 were rejected as false positives after subjecting to FDR
analysis using the Benjamini-Hochberg’s method [10]. An adjusted p-value of
less than 0.03125 was considered as statistically significant.
doi:10.1371/journal.pone.0039476.t001
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Differentially expressed protein spots were excised manually
from 2-DE gels, and washed with 100 mM NH4HCO3 for
15 min. The gel plugs were then destained twice with 15 mM
potassium ferricyanide/50 mM sodium thiosulphate with shaking.
They were then reduced with 10 mM DTT at 60uC for 30 min
and alkylated with 55 mM iodoacetamide in the dark at room
temperature for 20 min. The plugs were later washed thrice with
500 ml of 50% ACN/ 50 mM NH4HCO3 for 20 min, dehydrated
with 100% ACN for 15 min and dried using the SpeedVac. The
gel plugs were finally digested in 6 ng/ml trypsin (Pierce, Rockford,
IL USA), in 50 mM NH4HCO3 at 37uC for at least 16 h. Peptide
mixtures were then extracted twice with 50% ACN and 100%
ACN, respectively, and finally concentrated using the Speedvac
until completely dry. The dried peptides were then kept at –20uC
or reconstituted with 10 mL of 0.1% TFA prior to desalting using
the Zip Tip C18 micropipette tips (Millipore, Billerica, MA, USA).
Mass spectrometry and database search
Peptide mixtures were analysed by MALDI-TOF/TOF using
an Applied Biosystems 4800 Plus MALDI-TOF/TOF (Foster
City, CA, USA), after the trypsin digest were crystallized with
alpha-cyano-4-hydroxycinnamic acid matrix solution (10 mg/ml,
70% ACN in 0.1% (v/v) TFA aqueous solution) and spotted onto
Figure 3. IPA graphical representation of the molecular relationships between differentially expressed proteins in HepG2 cells
treated with T. indica extract. The network is displayed graphically as nodes (proteins) and edges (the biological relationships between the nodes).
Nodes in red indicate up-regulated proteins while those in green represent down-regulated proteins. Nodes without colors indicate unaltered
expression. Various shapes of the nodes represent the functional class of the proteins. The different arrow shapes represent different types of
interactions. Edges are displayed with various labels that describe the nature of the relationship between the nodes. Names of proteins
corresponding to the abbreviations are as follows: APOA1, Apolipoprotein A-1; APOA2, Apolipoprotein A-2; APOA4, Apolipoprotein A-4; APOA5,
Apolipoprotein A-5; APOC1, Apolipoprotein C-1; APOC2, Apolipoprotein C-2; APOE, Apolipoprotein E; APOM, Apolipoprotein M; APOL1,
Apolipoprotein L-1; ACACB, acetyl-CoA-carboxylase 2; SAA2, serum amyloid A2; LCAT, lecithin cholesterol acyltransferase; PLTP, phospholipid transfer
protein; CETP, cholesterylester transfer protein; PTGIS, prostaglandin I synthase; RAB9A, Ras-related protein Rab 9A; RAB6A, Ras-related protein Rab
6A; GDI2, Rab GDP dissociation inhibitor beta; RAB2A, Ras-related protein Rab 2A; KCNMA1, Potassium large conductance calcium-activated channel,
subfamily M, alpha member 1; DDR1, discoidin domain receptor tyrosine kinase 1; TTR, transthyretin; RBP4, retinol binding protein 4; LIPC, hepatic
triglyceride lipase; LIPG, endothelial lipase; PON1, paraoxonase 1; HPX, haemopexin; Tcf 1/2/3, T-cell factor -1, -2, -3; Rbp, retinol binding proteins.
doi:10.1371/journal.pone.0039476.g003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39476Figure 4. Predicted canonical pathway affected by T. indica fruit extract. IPA identified ‘LXR/RXR activation’ as the canonical pathway with
the highest predicted potential/significance of being affected by the altered levels of TTR, ApoA-I and GDI-2 in HepG2 cells that were treated with T.
indica fruit extract. Lines between the proteins represent known interactions. Red nodes indicate overexpression of genes induced by the extract,
which was based on our previous report [8]. Abbreviation: ABCA1, ATP-binding cassette sub-family A member 1; ABCG1, ATP-binding cassette sub-
family G member 1; ABCG5, ATP-binding cassette sub-family G member 5; ABCG8, ATP-binding cassette sub-family G member 8; ECHS, enoyl CoA
hydratase; HADH, hydroxyacyl-CoA dehydrogenase; HMGCR, HMG-CoA reductase; CYP7A1, cytochrome P450, family 7, subfamily A, polypeptide 1;
LDLR, low density lipoprotein receptor; CETP, cholesterylester transfer protein; CD36, cluster of differentiation 36; NCOR, nuclear receptor corepressor;
LXR, liver X receptor; RXR, retinoid X receptor; 9-cis-RA, 9-cis-retinoic acid; LPL, lipoprotein lipase; PLTP, phospholipid transfer protein; SREBP-1c, sterol
regulatory element-binding protein 1c; FASN, fatty acid synthase; SCD1, stearoyl-conzyme A desaturase 1; ACC, acetyl-CoA carboxylase; APOA4,
apolipoprotein A-4; LDL, low density lipoprotein; HDL, high density lipoprotein.
doi:10.1371/journal.pone.0039476.g004
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ically acquired with a trypsin autodigest exclusion list and the 20
most intense ions selected for MS/MS analysis. Interpretation was
carried out using the GPS Explorer software (Applied Biosystems,
CA, USA) and database search using the in-house MASCOT
program (Matrix Science, London, UK). Both combined MS and
MS/MS searches were conducted with the following settings:
Swiss-Prot database, Homo sapiens, peptide tolerance at 200 ppm,
MS/MS tolerance at 0.4 Da, carbamidomethylation of cysteine
(variable modification) and methionine oxidation (variable mod-
ifications). A protein is considered identified when a MASCOT
score of higher than 55 and p,0.05 were obtained from the MS
analysis.
Functional Analysis by IPA
The proteomics data was further analysed using the Ingenuity
Pathways Analysis (IPA) software (IngenuityH Systems, www.
ingenuity.com) to predict networks that are affected by the
differentially expressed proteins. Details of proteins identified to be
differentially released, their quantitative expression values (fold
change difference of at least 1.5) and p-values (p,0.05) were
imported into the IPA software. Each protein identifier was
mapped to its corresponding protein object and was overlaid onto
a global molecular network developed from information contained
in the Ingenuity Knowledge Base. Network of proteins were then
algorithmically generated based on their connectivity. Right-tailed
Fischer’s exact test was used to calculate a p-value indicating the
probability that each biological function assigned to the network is
due to chance alone.
Results
Viability of HepG2 cells
To determine the influence of serum-free medium and the
methanol extract of T. indica fruit pulp on viability of HepG2 cells,
the MTT analysis was carried out. Our results showed no
significant difference in viability of cells that were grown in
complete or serum-free media (Figure 1A). Viability of HepG2
cells that were grown in the presence of the methanol extract of
the T. indica fruit pulp at a final concentration of 60 mg/ml was
also not significantly different from those grown in the control
serum-free medium in the presence of 0.02% (v/v) DMSO
(Figure 1B).
2D-GE analysis of proteins released from HepG2 cells
When culture supernatants of HepG2 cells were subjected to
2D-GE, more than 1500 highly resolved protein spots were
detected in each gel. Figure 2 demonstrates typical 2D-GE
resolved patterns of the proteins released from control (panel A)
and T. indica-treated HepG2 cells (panel B). The percentage of
volume contribution of each spot was then determined using the
ImageMaster 2D Platinum V 7.0 software, and the fold change, if
any, was acquired. Protein spots that were present in all gels (n=4)
and showed significant difference in their expression (p,0.05) in
the culture media of treated and non-treated cells by more than
1.5 fold were initially selected. Based on these criteria, nine protein
spots were initially found to be differentially expressed, four of
which were significantly up-regulated and five significantly down-
regulated. When the data were further subjected to false discovery
rate (FDR) analysis based on the Benjamini-Hochberg’s method
[9], two of the protein spots were categorized as false positives and
excluded (Table 1). The seven proteins spots that were concluded
to be differentially expressed when HepG2 cells were treated with
T. indica were those designated with numbers 46, 148, 460, 468,
661, 666 and 810 as shown in Figure 2.
Identification of differentially expressed proteins
Among the seven protein spots that were altered in expression,
five spots (46, 148, 460, 468 and 810) were identified by mass
spectrometry and database search. Spots 661 and 666 were not
successfully identified by MS/MS analysis as their scores were
lower than the cut off value for positive inclusion criteria. This
could probably be due to their close proximity to the high
abundant proteins which hinder the detection of their peptides.
The five differentially expressed proteins that were identified
include transthyretin (TTR – spot 46), two isoforms of apolipo-
protein A-I (ApoA-I – spots 148 and 810), alpha enolase (ENO1 –
spot 460) and rab GDP dissociation inhibitor beta (GDI-2 – spot
468) (Table 2). ENO1 and GDI-2 were apparently up-regulated by
approximately 2-fold, while TTR was down-regulated by 2.5-fold.
The two spots identified as ApoA-1 was down-regulated by 2.2-
and 1.7-folds.
Pathway interactions and biological process analysis
Analysis using IPA identified ‘‘Lipid Metabolism, Molecular
Transport and Small Molecule Biochemistry’’ as the sole putative
network linking three of the differentially expressed proteins with
other interactomes, with a score of 9. A score of 2 or higher
indicates at least a 99% confidence of not being generated by
random chance and higher scores indicate a greater confidence.
Figure 3 shows a graphical representation of the predicted
molecular relationships between ApoA-I, TTR and GDI-2. The
network suggests T.indica fruit pulp extracts affect lipid metabo-
lism, converging on beta-estradiol. A canonical pathway analysis
ranked the LXR/RXR activation with the highest significance
(p,1.29610
204; Figure 4).
Discussion
In this study, proteomic techniques were used to analyze the
expression of proteins that were released by HepG2 cells in
response to treatment with the methanol extract of T. indica fruit
pulp. Serum-free DMEM culture media from HepG2 cells grown
for 24 hours in the absence and presence of T. indica fruit pulp
extract were initially subjected to 2D-GE. The use of serum-free
medium was necessary for the proteomic analysis to avoid masking
of the proteins released by the cells by those present in FBS. The
results of our MTT assays showed that viability of the HepG2 cells
was not affected by use of serum-free medium and neither was it
significantly different when the cells were exposed to the T. indica
fruit pulp extract.
Among the thousands of protein spots that were detected in the
2D-GE profiles of culture media isolated from HepG2 cells grown
in the absence or presence of the methanol extract of T. indica fruit
pulp, only seven were found to be altered in expression. Five of the
protein spots were found to be those of TTR, ENO1, GDI-2 and
ApoA-I (2 isoforms), whilst two spots were not successfully
identified Exposure of the HepG2 cells to the T. indica fruit pulp
extract appeared to have caused the increased release of ENO1
and GDI-2 but decreased secretion of TTR and ApoA-I. While
the two latter proteins are known to be secretory proteins, ENO1
and GDI-2 are apparently cytosolic proteins [10]. However,
several earlier studies had also detected the presence of ENO1 and
GDI-2 in the culture media of HepG2 cells [11,12].
When the differentially expressed proteins were subjected to
analysis using IPA, all but ENO1 were found to be interconnected
with interactomes in lipid metabolism. ENO1, although more
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functional protein that also acts as a receptor, activator and
regulator molecule [13,14]. Hence, the ENO1 that was detected in
the culture media in this study may not be involved in glycolysis.
Due to the multiple roles played by ENO1, it is difficult to
speculate the reason why the release of the protein was increased
when HepG2 cells were exposed to the T. indica fruit pulp extract.
Interestingly, the three differentially expressed proteins that are
involved in lipid metabolism appeared to be commonly associated
with the same hormonal regulation, i.e., estradiol, and the
homeostasis of cholesterol. GDI-2 functions to translocate
prenylated Rab proteins from the cytosol to the membrane to
form nascent transport vesicles. The protein also assists the
subsequent retrieval of Rab proteins [10,15], which are key
regulators for the transport of lipids and proteins between cell
organelles from target membranes [15,16,17]. To date, approx-
imately 70 Rab proteins had been identified but their specific
functions are still largely unknown [18]. These include Rab11,
whose overexpression has been shown to block the recycling of
cholesterol from the endosome recycling compartment to the
plasma membrane [19,20]. On the other hand, Rab8 has been
shown to assist the redistribution of cholesterol from late
endosomes to the cell periphery and stimulate cholesterol efflux
through the ABCA1/ApoA-I pathway [21]. The increased release
of GDI-2 by HepG2 cells when they were exposed to the methanol
extract of T. indica fruit pulp was probably to enable the recycling
of Rab proteins that are involved in the cholesterol homeostasis in
the cell.
TTR is a protein that is mainly synthesized in the liver and the
choroid plexus of the brain [22]. Its two main functions are to
transport thyroxine and retinol through binding to the hormone
and retinol-binding protein, respectively [23,24]. However, a small
fraction of plasma TTR (1–3%) is apparently associated with
ApoA-I, the major apoprotein found in the anti-atherogenic
lipoprotein HDL. ApoA-I is synthesized in the liver (as well as the
intestine) and its secretion is believed to be either in a lipid-free/
poor or pre-lipidated forms (intracellularly assembled nascent
HDL) [25]. Ohnsorg [26], Liz [27] and their coworkers showed
that TTR cleaves the C-terminus of ApoA-I, which is necessary for
the transport of lipid-free ApoA-I through the aortic endothelial
cells. When HepG2 cells were exposed to the tamarind extract in
this study, secretion of both TTR and ApoA-I was reduced by
more than 2-fold. The two proteins were also shown to be
interconnected via our IPA analysis. This alteration reflects the
indirect effects of T. indica fruit pulp extract in regulating the
function of HDL in the reverse transport of cholesterol and also in
line with the earlier findings on the cholesterol and triacylglycerol
lowering effects of the fruit extract in hypercholesterolaemic
hamsters [4] and in humans [5].
In our recent report, we have also described the up-regulated
expression of the APOA1 gene by 1.2 fold when HepG2 cells were
exposed to the same concentration of T. indica fruit pulp extract
[8]. The high ApoA-I mRNA levels that were detected in HepG2
cells upon exposure to the extract as opposed to the low levels of
ApoA-I that appeared in the media could be either due to the
decrease in the rate of export of the apoprotein or that the mRNA
may not be translated into ApoA-I. Our previous study also
showed that the T. indica fruit pulp extract induced the expression
of the ABCG5 gene. ABCG5 apparently forms a dimer with
ABCG8 to assist the secretion of cholesterol into the bile and its
subsequent excretion via the faeces. Therefore, the lower ApoA-I
secretion that was detected in the present study suggests that the T.
indica fruit pulp extract may be promoting the excretion of
cholesterol via the ABCG5 instead of the ApoA-I transport system.
Interestingly, the ABCG5/8-mediated cholesterol excretion and
absorption and ABCA-1-mediated cholesterol efflux are appar-
ently controlled by the liver X receptors, LXRs. Earlier studies
have apparently shown that proanthocyanidins, which constitutes
more than 73% of the total phenolic content of T. indica extract
[6], were able to modulate the activation of LXR/RXR [28].
Hence, the data of this study, when taken together with that of our
earlier report, suggest that the T. indica fruit pulp extract exerts its
lipid lowering effects through the modulation of the LXRs,
a conception that was similarly derived from the canonical
pathway analysis.
Conclusion
The methanol extract of T. indica fruit pulp altered the release of
ENO1, ApoA-I, TTR and GDI-2 from HepG2 cells. Our results
provide support on the predicted effect of T. indica extract on
cellular lipid metabolism, particularly that of cholesterol.
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